连续性血液净化联合清胰利胆颗粒治疗重症急性胰腺炎的应用价值

表3 两组患者治疗前后AMS、LPS、Cr、AST、ALT、PCT等生化指标的比较 (mean ± SD)

检测指标	对照组 (n = 70)		观察组 (n = 80)
	治疗前	治疗后5 d	治疗前	治疗后5 d
AMS (U/L)	613.31 ± 81.56	453.76 ± 72.35	621.87 ± 86.91	236.35 ± 67.32a
LPS (U/L)	184.91 ± 32.69	106.22 ± 23.58	185.33 ± 33.61	89.06 ± 20.61a
Cr (μmol/L)	263.06 ± 60.58	182.39 ± 29.46	264.12 ± 61.52	117.09 ± 20.19a
AST (μmol/L)	310.91 ± 78.93	152.28 ± 30.37	312.33 ± 79.61	109.25 ± 21.21a
ALT (μmol/L)	263.31 ± 71.61	131.08 ± 21.22	265.28 ± 72.06	89.25 ± 17.21a
PCT值(ng/L)	22.88 ± 4.01	15.12 ± 2.01	23.12 ± 5.21	12.05 ± 1.71a

^aP<0.05与对照组治疗后比较. AMS: 血清淀粉酶; LPS: 血清脂肪酶; Cr: 肌酐; AST: 谷草转氨酶; ALT: 谷丙转氨酶; PCT: 降钙素原.